Loading viewer...
investor_presentation
Format: PDF investor_presentation
Immunic Therapeutics is developing a pipeline of next-generation selective oral therapies for chronic inflammatory and autoimmune diseases. The presentation outlines the company's lead product candidates including IMU-838, IMU-935, and IMU-856, with details on clinical trial timelines and commercial strategy.
investor_presentation
29 Pages
Bazalgette Tunnel Limited (Tideway)
investor_presentation
Infineon
Samsung Memory Investor Presentation 2023
investor_presentationinvestor_presentation
23 Pages
Samsung Electronics Co., Ltd.